D.A. DAVIDSON & CO. - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 40 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$1,000
-66.7%
2,0000.0%0.00%
Q1 2017$3,0002,0000.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Prospera Financial Services Inc 176,100$287,0000.05%
RFG Advisory, LLC 40,000$65,0000.05%
Acrospire Investment Management LLC 16,551$29,0000.02%
HighTower Advisors, LLC 1,047,731$1,854,0000.02%
B. Riley Wealth Advisors, Inc. 25,958$46,0000.01%
EXENCIAL WEALTH ADVISORS, LLC 11,900$19,0000.01%
THOMPSON DAVIS & CO., INC. 3,000$5,0000.01%
LBA Wealth Management, LLC 8,000$14,0000.01%
INGALLS & SNYDER LLC 20,739$37,0000.00%
Vantage Investment Advisors, LLC 1,150$2,0000.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders